Purpose: To report on outcomes after contralateral autologous penetrating keratoplasty (APK).
T he first successful allogeneic penetrating keratoplasty (PKP) was performed in Czechoslovakia by Eduard Zirm in 1906. 1 This feat was quickly followed by the first contra-lateral autologous transplantation by lamellar technique in 1908. 2 It was not until 1958 that a fuller demonstration of the procedure was presented by Barraquer and Sambursky 3 and Barraquer and Ariza, 4 who reported 3 cases in which penetrating autokeratoplasty was successful.
Contralateral autologous penetrating keratoplasty (APK) is a good option in patients who have lost corneal function because of loss of clarity in a potentially seeing eye and have a clear cornea in an eye with poor or no vision because of noncorneal disease. [5] [6] [7] [8] Because the transplanted tissue is isogenic, there is no risk of immunological graft rejection. Accordingly, the surgery is especially beneficial in patients at high risk for graft rejection (eg, multiple graft failure). Autologous grafts have been reported to remain clear and free of vascularization, even when transplanted into densely vascularized host beds. 4, 5, 7, [9] [10] [11] [12] [13] Furthermore, this surgery is of benefit when poor compliance with postoperative topical medications is likely or where ophthalmic services are limited. 12 However, given the necessary preoperative criteria of a clear contralateral cornea with poor visual potential, opportunities do not frequently present themselves for its use. 9, 14 Since 1908, there have been sporadic publications covering approximately 47 patients who underwent contralateral autologous PKP with generally good results. The overall mean time frame for follow-up was 23 months (range, 0.1-216 months) from 39 patients recorded (Table 1) . 2, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Of those patients, 7 complications have been described including 1 patient with an immediate postoperative complication (poor suture healing after surgery) 15 and 6 patients with later complications from uveitis, 8 retrocorneal membrane growth, posterior epithelial downgrowth, infection after retinal surgery, 15 superficial punctate keratopathy, 21 and corneal scarring because of dry eye syndrome. 11 We report the first cases of late endothelial failure after autologous PKP surgery to make clinicians aware of this potential complication and highlight the need to better understand factors associated with ongoing endothelial cell loss after successful surgery.
MATERIALS AND METHODS
As all cases were performed and reviewed by the study authors (2 by A.G. and 3 by E.C.A.), the project was deemed to meet criteria for a case series by the University of Miami and the Miami Veterans Affairs Medical Center institutional review boards. Therefore, no institutional review board submission was required before reviewing the cases. The study was conducted in accordance with the principles of the Declaration of Helsinki.
Study Population
Retrospective case series of patients who underwent APK at the Miami Veterans Affairs Administration Hospital and Bascom Palmer Eye Institute. During the period between 1990 and 2011, 5 APK procedures were performed. Information collected from patient charts included preoperative history, operative information, and postoperative course.
Surgical Technique
The surgical technique involved removing the donor cornea (in the blind eye) by full-thickness trephination using a Hessburg-Barron instrument after the anterior chamber (AC) aqueous humor was replaced by a viscoelastic. The cornea was then placed in eye bank corneal donor preservation (Optisol) media. An allograft was sutured into place using 16 interrupted 10-0 nylon sutures. In cases 2, 3, and 4, the eye with the corneal disease was trephined using a Hessburg-Barron instrument and the recipient donor autograft was then sutured with 16 interrupted 10-0 nylon sutures. In cases 1 and 5, a temporary keratoprosthesis was placed followed by pars plana vitrectomy and glaucoma tube repositioning (case 1) or placement (case 5) into the vitreous and then the donor was sutured into place using 16 interrupted 10-0 nylon sutures. In all patients, prednisolone acetate 1% was started 4 days before surgery in both eyes and continued at this dose after surgery.
RESULTS
Five patients underwent contralateral APK surgery over a 12-year period. Median age at the time of surgery was 67 years (range, 58-88 years); 4 patients were male ( Table 2) .
All patients had complicated ophthalmic histories in the recipient APK eye including previous graft failure in 4 patients, glaucoma in 5 patients, the presence of a glaucoma drainage device (GDD) in 4 patients, pseudophakia in 5 patients, and anterior synechiae in 2 patients. All donor eyes had a history of glaucoma but no GDD, and all had normal AC organization. Preoperative endothelial cell density information was available in 2 patients for the donor eye and was 2545 cells per square millimeter in case 3 and 995 per square millimeter in case 4.
All patients underwent APK surgery from the donor eye to the recipient eye, simultaneously receiving an allogeneic PKP in the donor eye. There were no operative or postoperative complications. All APK grafts were initially clear with improvement of best-corrected visual acuity in 4 of 5 patients; visual acuity in 1 patient did not improve because of glaucoma.
During a median follow-up of 34 months, 4 of the 5 APK grafts failed without any evidence of inflammation or an immune reaction ( Table 2 ). Below are case descriptions of the 5 patients.
Case 1
A 62-year-old black man presented for decreased vision in the left eye. Ocular history was significant for absolute glaucoma in the right eye. His left eye had a history of GDD placement, cataract extraction with posterior chamber intraocular lens implantation, and synechiolysis. At the time of presentation, the patient's visual acuity was no light perception (NLP) in the right eye and hand motions (HM) in the left eye. Slit-lamp examination of the right eye revealed a clear cornea with pachymetry of 521 mm. Findings in the left eye included a thickened cornea with pachymetry of 810 mm, 360-degree high peripheral anterior synechiae, shallow AC depth, and a GDD tube in near proximity to the cornea.
The patient underwent APK surgery from the right eye to the left eye, simultaneously receiving an allogeneic PKP in the right eye ( Table 2 ). Three months after surgery, best visual acuity improved to 20/40 vision and both corneal transplants were clear. Sixteen months after surgery, visual acuity measured 20/200 in the left eye and slit-lamp examination disclosed slight microcystic edema, haze, and thickening of the graft with a pachymetry of 717 mm. No signs of immunological rejection were noted. Despite increased prednisolone use, the corneal appearance remained unchanged with pachymetry readings of 468 mm on the right eye and 695 mm on the left eye.
Case 2
An 82-year-old black woman presented for vision loss in the right eye. Her ocular history was significant for glaucoma and cataract surgery in both eyes. The patient's right eye also had a history of PKP combined with GDD placement. At presentation, the patient's visual acuity was HM in the right eye and light perception (LP) in the left eye. Slit-lamp examination of the right eye was notable for a thickened corneal graft with pachymetry of 1004 mm, a well-positioned GDD, and a well-centered AC intraocular lens. Examination of the left eye revealed a clear cornea with pachymetry of 457 mm.
The patient underwent APK from the left eye to the right eye, simultaneously receiving an allogeneic PKP in the left eye (Table 2 ). One week after surgery, visual acuity was 8/200 E and the cornea was noted to be clear; however, a fibrin membrane was noted anterior to the lens and the AC was found to be shallow. Five months after surgery, visual acuity improved to 20/100 in the right eye with normal intraocular pressure; however, mild cornea edema was observed. Seven months after surgery, the patient presented with a decreased vision in the right eye and a visual acuity of 20/200. Slit-lamp examination disclosed worsening corneal edema with no signs of immunological rejection. The patient underwent a second allogeneic PKP with extraction of a pupillary membrane 1 year after APK.
Case 3
A 67-year-old black man presented for corneal transplant failure in his left eye. His ocular history was significant for absolute glaucoma in the right eye. His left eye had multiple procedures including 2 trabeculectomies, 2 GDDs, cataract extraction, and 2 PKPs. At presentation, the patient's visual acuity was NLP in the right eye and 4/200 E in the left eye. Slit-lamp examination of the right eye revealed a clear cornea with pachymetry of 544 mm and endothelial cell count of 2545 cells per square millimeter. Left eye revealed a GDD away from the graft and corneal edema with a pachymetry of 612 mm and an endothelial cell count of 921 cells per square millimeter.
The patient underwent APK from the right eye to the left eye and simultaneously received an allogeneic PKP in the right eye (Table 2) . One month after surgery, best visual acuity improved to 5/200 E with normal intraocular pressure and clear grafts in both eyes. Thirty months after surgery, visual acuity decreased to HM in the left eye and slit-lamp examination showed new corneal edema with no signs of corneal rejection. A third allogeneic PKP was performed with tube repositioning almost 3 years after the APK.
Case 4
An 88-year-old white man presented for corneal graft failure in the right eye. His ocular history was significant for glaucoma, hypertensive retinopathy, and Fuchs endothelial dystrophy in both eyes. Loss of vision in the left eye occurred because of a central vein occlusion. The patient's right eye underwent several procedures including cataract surgery, 2 trabeculectomies, 3 PKPs, and GDD placement. At presentation, the patient's visual acuity was LP in the right eye and NLP in the left eye. Right eye examination revealed a thickened opaque graft with 4+ Descemet folds. Left eye examination revealed a clear cornea with a corneal thickness of 469 mm and an endothelial cell count of 1005 cells per square millimeter.
The patient underwent APK from the left eye to the right eye and simultaneously received an allogeneic PKP in the left eye ( Table 2) . Two months after surgery, visual acuity improved to 4/200 E and both corneas were clear. Six months after surgery, the patient had a decrease in visual acuity to LP and slit-lamp examination revealed a right eye with a pupillary membrane and an opacified graft. Ultrasonography revealed a right eye retinal detachment. One year and 8 months after APK, a fifth PKP and retinal detachment repair were attempted but were unsuccessful.
Case 5
A 58-year-old black man presented for corneal transplant failure in the right eye. His ocular history was significant for endophthalmitis and end-stage glaucoma in the left eye. The patient's right eye had a history of uveitis and glaucoma. The patient had multiple procedures in the right eye including a Baerveldt glaucoma implant (BGI), cataract extraction, PKP with removal of fibrinous membrane, and later BGI removal. At presentation, the patient's visual acuity was LP in the right eye and NLP in the left eye. Slit-lamp examination of the right eye revealed a hazy, opacified, thickened cornea, 360 degrees of iridocorneal touch, and 360 degrees of corneal neovascularization extending onto the graft peripherally. The left eye revealed a clear cornea.
The patient underwent APK from the left eye to the right eye and simultaneously received an allogeneic PKP in the left eye ( Table 2 ). Almost 2 years after APK, the patient had stable visual acuity of LP and both corneal grafts remained clear. Complete cupping of the right optic nerve explained the lack of visual improvement after surgery.
DISCUSSION
Autologous PKP surgery is a potentially advantageous technique as it eliminates the risk of immunologic rejection of foreign tissue. However, our cases illustrate that this technique does not eliminate the risk of failure because of other causes. Our case series is the first to report on late endothelial failure after contralateral APK. These cases help answer the question of whether graft failure in the absence of clinical signs of rejection represents subclinical rejection or endothelial attenuation because of other causes. Our cases lend support to the idea that other factors, besides immune response to foreign antigen, may be responsible for graft failure in this situation. Understanding these factors is critical for the attainment of optimal results after surgery.
Data from the Corneal Donor Study demonstrated that ongoing endothelial cell loss is a problem plaguing the field of corneal transplantation. 23 In grafts considered at low risk for immunologic rejection, the central cell density continued to decrease year after year with a median decrease of 70% at 5 years after corneal transplantation. 23 Although the specific processes behind this cell loss are not fully understood, several risk factors have been identified that increase the overall risk of graft failure including the presence of glaucoma, 24, 25 GDDs, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] anterior synechiae, 24 previous graft failure, 24, 31 and small graft size. 24, 25 In comparing our 5 APK patients with those in the literature, our patients were at overall higher risk for graft failure when considering the above criteria. We hypothesize that factors such as GDD and the presence of anterior synechiae contributed to the ultimate graft failure in our APK patients. All our recipient eyes had glaucoma compared with 12 of 47 of historical controls. Furthermore, all recipient eyes in our series had a GDD (4 before surgery and 1 placed at the time of APK surgery) compared with 1 of 47 in historical APK cases.
Other factors that likely elevated the risk of failure in our patients included the presence of anterior synechiae (2/5 cases) and previous PKP (4/5 cases), which were found in only 5 of 47 of the reported APK cases.
The exact mechanism for why these risk factors increase the risk of graft failure is not fully elucidated and is likely multifactorial. With regard to glaucoma, one potential mechanism could be an increase in oxidative stress. [36] [37] [38] A case-control study comparing aqueous humor antioxidant enzymes in patients with glaucoma (n = 24) and cataract patients without glaucoma (n = 24) showed significant increases in superoxide dismutase and glutathione peroxidase activity in patients with glaucoma compared to patients without glaucoma. 36 With regard to GDD, possibilities include mechanical trauma during placement; ongoing trauma because of eye movements, rubbing, and blinking; and changes in the AC milieu. 28, 39 A study comparing proteins in patients with (n = 11) and without GDD (n = 11) found significant increases in proinflammatory proteins in GDD eyes. 39 Given the issue of endothelial loss after surgery, our present approach to maximize endothelial health is to start prednisolone in the donor eye before surgery (typically 4 days before surgery) as some studies have demonstrated a positive effect of corticosteroids on endothelial cells through increased Na,K-ATPase activity. 40 Other studies, however, failed to observe an effect of corticosteroids on corneal endothelial regeneration. 41, 42 Other considerations include using a large graft to transplant the maximum number of endothelial cells and moving glaucoma tubes from the AC to the vitreous. Despite such measures, 4 of our grafts failed, highlighting the need for better endothelial protective agents. One such potential class of compounds is Rho-associated protein kinase inhibitors. Rho-associated protein kinase is a protein involved in regulating the cytoskeleton, cell migration, apoptosis, and proliferation. 43 In a rabbit model, the use of a topical Rhoassociated protein kinase inhibitor after cryogenic injury improved corneal transparency, wound healing, and corneal thickness compared with a control group. 44 As with all studies, this work has limitations that need to be considered when interpreting the study results, including a small sample size, the use of various topical medications (eg., carbonic anhydrase inhibitors), nonuniform surgical techniques, and variable postsurgical management. Furthermore, information on preoperative endothelial cell density and pachymetry was not available in all patients. Another limitation is that all donor eyes had some ocular pathology (eg., glaucoma), which may have affected overall endothelial health. Despite these limitations, our cases illustrate that although APK surgery has many advantages, this technique does not eliminate the risk of overall graft failure. This finding emphasizes that research on nonimmunological factors that lead to endothelial attenuation after surgery is greatly needed. A better understanding of such factors will allow us to develop more specific endothelial protective therapies that can improve the prognosis after autologous and allogeneic corneal transplantation alike.
